Findings of <scp>¹⁸F‐PI</scp>‐2620 tau <scp>PET</scp> imaging in patients with Alzheimer’s disease and healthy controls in relation to the plasma P‐tau181 levels in a Japanese sample

Abstract

Our results add to accumulating evidence suggesting that ¹⁸ F-PI-2620 is a promising tau PET tracer that allows patients with AD to be distinguished from healthy controls, although a study with a larger sample size is warranted.